TLR3 and TLR4 as potential clinically biomarkers of cardiovascular risk in coronary artery disease (CAD) patients

Toll-like receptor 3 and 4 signalling through the TRIF and TRAM adaptors in haematopoietic cells promotes atherosclerosis

(2013) Anna M. Lundberg et al.   CARDIOVASCULAR RESEARCH

Palmitate induces interleukin-8 expression in human aortic vascular smooth muscle cells via Toll-like receptor 4/nuclear factor-κB pathway (TLR4/NF-κB通路介导了软脂酸诱导人主动脉血管平滑肌细胞白细胞介素-8的基因表达)

(2013) Jinxing Quan et al.   Journal of Diabetes

The Role of Toll-Like Receptors in Diabetes-Induced Inflammation: Implications for Vascular Complications

(2012) Ishwarlal Jialal et al.   Current Diabetes Reports

Left circumflex coronary artery is protected against no-reflow phenomenon following percutaneous coronary intervention for coronary artery disease

(2012) Toshiyuki Nagai et al.   HEART AND VESSELS

The LPS2 mutation in TRIF is atheroprotective in hyperlipidemic low density lipoprotein receptor knockout mice

(2012) M Rachel Richards et al.   Innate Immunity

Type I Interferon Inhibits Interleukin-1 Production and Inflammasome Activation

(2011) Greta Guarda et al.   IMMUNITY

Unexpected protective role for Toll-like receptor 3 in the arterial wall

(2011) J. E. Cole et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Alternative Activation of Macrophages: Mechanism and Functions

(2010) Siamon Gordon et al.   IMMUNITY

The Expression and Functions of Toll-Like Receptors in Atherosclerosis

(2010) Jennifer E. Cole et al.   MEDIATORS OF INFLAMMATION

Effects of Statins on Adipose Tissue Inflammation

(2008) Manabu Abe et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

A combination of Lox-1 and Nox1 regulates TLR9-mediated foam cell formation

(2008) Jin-Gu Lee et al.   CELLULAR SIGNALLING